Dermatol. praxi. 2016;10(1):38-42 [Urol. praxi, 2015; 16(3): 116-120]
Human papillomavirus
- 1 Urologické oddělení, Oblastní nemocnice Mladá Boleslav
- 2 Chirurgické oddělení a urologická ambulance, Panochova nemocnice Turnov/Krajská nemocnice Liberec
- 3 Urologická klinika, Fakultní nemocnice Královské Vinohrady, Praha
Infections caused by the human papillomaviruses (HPV) are the most common sexually transmitted diseases worldwide (1). A papillomavirus infection is encountered by more than a half of sexually active men and women at some point in their lives. Only about 1% of anogenital HPV infections (particularly types 6 and 11) are clinically manifested and can result in developing macroscopically distinct lesions (condylomata acuminata). Certain HPV types can induce the development of dysplastic or malignant changes. Only symptomatic visible lesions are treated in patients. There are a number of treatment options, with their choice being driven by the preferences of both the physician and the patient.
Keywords: human papillomavirus, condylomata acuminata, vaccination
Published: April 1, 2016 Show citation
References
- Matoušková M, Hanuš M. Infekce high risk HPV (vysokorizikovým lidským papilomavirem) u muže. Lokální aplikace 5-fluorouracilu u podofylinrezistentních typů. Urolog. Praxi, 2006; 6: 276-277.
- Oriel JD, Almeida JD. Demonstration of virus particles in human genital warts. Br J Vener Dis 1970; 37: 37.
Go to original source... 
Go to PubMed... - de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of papillomaviruses. Virology. 2004; 324: 17-27. Go to original source... Go to PubMed...
- Kolombo I. Infekce lidským papillomavirem (Human papillomavirus-HPV), www.euni.cz.
- Porš J, Kolombo I, Hanuš T, Poršová M. Sexuálně přenosné nemoci. In: Kolombo I, Hanuš T, Porš J, Poršová M, et al. Infekce močových cest pro praktické lékaře a specialisty. Galén 2007: 125-129.
- Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003; 348: 518-527. Go to original source... Go to PubMed...
- IARC Working Group. IARC Monographs on the Evaluation Of Carcinogenic Risks to Humans: Human Papillomaviruses. Lyon, France: International Agency for Research on Cancer; 1995: 64.
- Berger RE, Lee JC. Sexually transmitted diseases: the clasic diseases. In Campbell's Urology CD-Rom, Walsh PC, Retik AB, Vaughan ED, Wein AJ, Volume 1, Section 4, Chapter 17, Copyright 2003, Elsevier Science (USA).
- Center for Disease Control and Prevention 2006. Sexually transmitted disease treatment guidelines. MMWR 2006: 51.
- Syrjanen KJ, Heinonen UM, Kauraniemi T. Cytologic evidence of the association of condylomatous lesions with dysplastic and neoplastic changes in the uterine cervix. Acta Cytol 1981; 25: 17. Go to original source...
- Mellinger BC. Human papillomavirus in the male: An overview. AUA Update Series 1994; Lesson 13, Volume XIII.
- Siegel JF, Mellinger BC. Human papillomavirus in the male patient. Urol Clin N Amer 1992; 19: 83-91. Go to original source...
- Šťáva Z. Kožní choroby vyvolané viry. In: Záruba F, et al. Dermatovenerologie. Praha, Karolinum 1992: 226-238.
- Van Opphofen A, Sch öfer H, Henke U, Lenz T, Eul A. Randomisierte Vergleichsstudie zur anhaltenden Wirksamkeit von Imiquimod 5 % Creme versus konventionelle ablative Methoden bei anogenitalen Condylomata acuminata. In: 59. Kongress der Deutschen Gesellschaft für Urologie; 2007; Abstrakt V.20.1. Berlin; 2007.
- Sláma J. Očkování proti HPV. Klin Farmakol Farm 2008; 22(4): 153-155.